Zenas BioPharma, Inc. (ZBIO) Reports Q2 Loss of $1.77
Tweet
Share
E-mailGet Alerts ZBIO Hot Sheet
Join SI Premium – FREE
Zenas BioPharma, Inc. (NASDAQ: ZBIO) reported Q2 EPS of ($1.77).Revenue for the quarter came in at $1 million.
For earnings history and earnings-related data on Zenas BioPharma, Inc. (ZBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- loanDepot receives NYSE non-compliance notice over stock price
- Hinge Health signs $86M office lease in San Francisco
- Solowin Holdings marks 10 years, expands into stablecoins and AI
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
